posts browsing tag

macrogen

Happy Birthday, Macrogen! Thank you for your support and love in Macrogen for the last 21 years! We have prepared a special event to thank our customers! &nbsp …

Continue reading

CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment research and development Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com), a precision medicine biotechnology company, announced on April 5 that it …

Continue reading

ROCKVILLE, MD– Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs …

Continue reading

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading

  What does it mean to map the human genome? Humans may be 99.9 per cent similar to one another, yet the miniscule remaining percentage spells all the difference – making one drug effective for one patient and life-threatening for another. Having a map of one’s genome means …

Continue reading